image: Medicare-funded multidisciplinary care is likely to be cost-effective in patients with chronic kidney disease. view more
Credit: Josh Plueger, US Air Force
Medicare-funded multidisciplinary care programs in the US are likely to be cost-effective in patients with mild to moderate chronic kidney disease (CKD), according to a new study published this week in PLOS Medicine by Eugene Lin from Stanford University, California, USA, and colleagues.
Multidisciplinary care--when healthcare providers of different expertise collaborate to treat a single disease--has been shown to reduce mortality and the incidence of end-stage renal disease in patients with CKD, but the cost-effectiveness of such programs remains unclear. In the new study, researchers used a modeling approach to estimate the cost-effectiveness of a theoretical Medicare-based multidisciplinary care program, including nephrologists, advanced practitioners, educators, dieticians, and social workers, for patients with stage 3 and 4 CKD.
Using Medicare claims data and data from published literature, they estimate that multidisciplinary care meets meet conventional cost-effectiveness thresholds in middle-aged to elderly patients with mild to moderate CKD, adding 0.23 (95% CI: 0.08, 0.42) quality-adjusted life years (QALYs) over usual care, with a cost of $51,285 per QALY gained. Multidisciplinary care was estimated to be generally more cost-effective in patients with higher urine albumin excretion. While the proposed program is theoretical and may not generalize to populations at low risk for progression to end stage renal disease, the findings provide evidence to support implementing Medicare-funded multidisciplinary care programs for patients with mild to moderate CKD.
In a linked Perspective, Richard Fluck and Maarten Taal from Royal Derby Hospital, UK, discuss some of the unknowns in implementing multidisciplinary programs for patients with CKD and argue for the need to develop packages of multidisciplinary care that are best suited to patients' risk profiles and CKD stage. The authors say "Much remains to be done to identify the optimal package of care for different patient subgroups, but we agree with the authors that the data provide sufficient evidence to support initiation of pilot MDC programmes as well as further research to identify optimal models for implementation."
###
Research Article
Funding:
This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (https://www.niddk.nih.gov/) and the National Institute on Aging (NIA) (https://www.nia.nih.gov/) of the National Institutes of Health. EL is supported by NIDDK F32DK107123. GMC was supported by NIDDK K24 DK085466. JDGF was supported by NIA K01 AG037593-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests:
I have read the journal's policy and the authors of this manuscript have the following competing interests: JDGF is a member of the Editorial Board of PLOS Medicine.
Citation:
Lin E, Chertow GM, Yan B, Malcolm E, Goldhaber-Fiebert JD (2018) Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study. PLoS Med 15(3): e1002532. https://doi.org/10.1371/journal.pmed.1002532
Author Affiliations:
Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America
Center for Health Policy/Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Palo Alto, California, United States of America
Duke University, Durham, North Carolina, United States of America
Division of General Medical Disciplines, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America
In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002532
Perspective
Funding:
The authors received no specific funding for this work.
Competing Interests:
We have read the journal's policy and the authors of this manuscript have the following competing interests: MWT is a member of the Editorial Board of PLOS Medicine.
Citation:
Fluck RJ, Taal MW (2018) What is the value of multidisciplinary care for chronic kidney disease? PLoS Med 15(3): e1002533. https://doi.org/10.1371/journal.pmed.1002533
Author Affiliations:
Department of Renal Medicine, Royal Derby Hospital, Derby, United Kingdom
Centre for Kidney Research and Innovation, Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham, Derby, United Kingdom
In your coverage please use this URL to provide access to the freely available paper:
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002533
Journal
PLOS Medicine